Delivery Order SPE2DB22D2206-SPE2DB24FGR90
- Not listed
- This federal contract award is a delivery order issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,466.97, is for the delivery of GRALISE ER 600 MG TABLET 90S, a medication, to Conshohocken, PA. The contract is a firm fixed-price arrangement with a completion date of May 19, 2025. Amerisourcebergen Drug Corp holds a substantial Indefinite Delivery Contract (IDC) with the DLA...
- This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $9,094.12 firm fixed-price delivery order is for GRALISE ER 600 MG TABLET 90S, a pharmaceutical product. The award has an ultimate completion date of June 18, 2025. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00. This prime...
- This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the delivery of GRALISE ER 600 MG TABLET 90S, a pharmaceutical product. The contract, valued at $1,937.32, was issued by the Defense Logistics Agency (DLA) Troop Support Medical on June 6, 2024 and has a completion date of June 7, 2024. Amerisourcebergen is a major supplier of pharmaceutical products and medical supplies to the U.S. federal government, including the Department of Defense (DoD) and...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of GRALISE ER 600 MG TABLET 90S, a pharmaceutical product. The contract has a firm fixed price of $1,051.65 and a completion date of May 21, 2025. The contract is not set aside and was competitively awarded. Amerisourcebergen Drug Corp holds a larger Indefinite Delivery Contract (IDC)...
- The federal contract award summarized in the provided information was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,803.80 Firm Fixed Price Delivery Order contract, with a completion date of February 4, 2025, is for the supply of GRALISE ER 600 MG TABLET 90S. This contract does not have a set-aside designation, indicating open competition. Amerisourcebergen holds a $999,999,999...
- This is a delivery order awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) Troop Support Medical for the supply of Gralise ER 600 mg tablets. The contract has a ceiling value of $5,616.54 and an ultimate completion date of September 13, 2024. This contract is not set aside for any specific business type. Amerisourcebergen holds significant Indefinite Delivery Contracts (IDCs) with the DLA Troop Support Medical and the Department...
- This federal contract award, valued at $3,539.70, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The award is a delivery order contract to supply 4,568,175,593 units of the prescription medication Gralise ER 600 mg tablets. The contract has a firm fixed price and an ultimate completion date of May 8, 2025. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with DLA Troop Support Medical,...
- This federal contract award was issued by the Defense Logistics Agency (DLA), a defense agency, to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $11,146.69, is a delivery order contract with a firm fixed price pricing type. The contract is not set-aside and has an ultimate completion date of July 18, 2025. The contract provides for the delivery of pharmaceutical products, including medications such as Gralise ER 600...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $3,799.72 firm fixed-price delivery order is for the supply of GRALISE ER 600 MG TABLET 90S, a prescription medication product. The contract, which has a period of performance ending on July 30, 2024, does not have a set-aside designation. Amerisourcebergen, through its Corporate Office division, has been awarded numerous contracts by various...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of GRALISE ER 600 MG TABLET 90S. The contract is a firm fixed price Delivery Order with a ceiling value of $1,787.25 and an ultimate completion date of June 23, 2025. This award is not a set-aside contract. Amerisourcebergen Drug Corp is a for-profit organization that serves as a critical supplier of medical and pharmaceutical products to...
- SPE2DB22D2206Indefinite Delivery Contract
- SPE2DB22D2206-SPE2DB24FGR90Delivery Order
This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division, a major pharmaceutical distributor. The $1,710.75 Delivery Order contract is for the supply of the prescription medication GRALISE ER 600 MG TABLETS in quantities of 90. The contract has a firm fixed price and an ultimate completion date of April 16, 2024. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 through December 31, 2025 with the DLA Troop Support Medical. This single-award IDC serves as the primary vehicle for Amerisourcebergen to provide a comprehensive range of pharmaceutical products and medical supplies to DLA facilities supporting the Department of Defense worldwide. The company also holds a smaller IDC with the Department of Justice Federal Bureau of Investigation for similar medical products and prescription drugs, valued up to $750,000 through May 2024. The contract was awarded on a full and open competition basis without any set-aside designations.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.7k | 4/15/24 |